Critical evaluation of secondary cytoreduction in recurrent ovarian cancer
- 1 November 2004
- journal article
- review article
- Published by Elsevier in Gynecologic Oncology
- Vol. 95 (2), 273-280
- https://doi.org/10.1016/j.ygyno.2004.09.018
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: Who benefits?Cancer, 2004
- Resection of recurrent ovarian or fallopian tube carcinoma involving the liver☆Gynecologic Oncology, 2003
- Hepatic resection for metachronous metastases from ovarian carcinomaGynecologic Oncology, 2003
- Secondary Cytoreductive Surgery for Patients with Recurrent Epithelial Ovarian CarcinomaGynecologic Oncology, 2001
- Secondary Cytoreductive Surgery for Localized Intra-abdominal Recurrences in Epithelial Ovarian CancerGynecologic Oncology, 2001
- Complete Salvage Surgical Cytoreduction Improves Further Survival of Patients with Late Recurrent Ovarian CancerGynecologic Oncology, 2000
- Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancerJournal of Surgical Oncology, 2000
- Cytoreductive Surgery in Ovarian Carcinoma Patients with a Documented Previously Complete Surgical ResponseGynecologic Oncology, 1995
- Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.Journal of Clinical Oncology, 1991
- Secondary cytoreductive surgery for recurrent epithelial ovarian cancerGynecologic Oncology, 1989